These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 28031126)

  • 21. Intralesional Vitamin D3 in Recalcitrant Palmoplantar and Periungual Warts: A Prospective, Observational Study.
    Priya A; Adil M; Amin SS; Mohtashim M; Bansal R; Alam M
    Acta Dermatovenerol Croat; 2019 Dec; 27(4):215-224. PubMed ID: 31969233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intralesional immunotherapy for non-genital warts: A systematic review and meta-analysis.
    Ju HJ; Park HR; Kim JY; Kim GM; Bae JM; Lee JH
    Indian J Dermatol Venereol Leprol; 2022; 88(6):724-737. PubMed ID: 35962514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Candida albicans intralesional injection immunotherapy of warts.
    Signore RJ
    Cutis; 2002 Sep; 70(3):185-92. PubMed ID: 12353895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intralesional immunotherapy compared to cryotherapy in the treatment of warts.
    Khozeimeh F; Jabbari Azad F; Mahboubi Oskouei Y; Jafari M; Tehranian S; Alizadehsani R; Layegh P
    Int J Dermatol; 2017 Apr; 56(4):474-478. PubMed ID: 28108992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of IL-12 serum level in patients with recalcitrant multiple common warts, treated by intralesional tuberculin antigen.
    Abd-Elazeim FM; Mohammed GF; Fathy A; Mohamed RW
    J Dermatolog Treat; 2014 Jun; 25(3):264-7. PubMed ID: 23336207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intralesional immunotherapy for pediatric warts: A review.
    Fields JR; Saikaly SK; Schoch JJ
    Pediatr Dermatol; 2020 Mar; 37(2):265-271. PubMed ID: 31930595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isotretinoin and candida immunotherapy for recalcitrant warts in solid organ transplant recipients.
    Herold M; Nielson C; Longo MI
    Dermatol Ther; 2019 Mar; 32(2):e12803. PubMed ID: 30536495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intralesional immunotherapy for multiple recalcitrant plantar warts: Candida antigen is superior to intralesional purified protein derivative.
    Nofal A; Adel L; Fawzy M; Elkholy BM
    Dermatol Ther; 2022 Jun; 35(6):e15440. PubMed ID: 35285995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful treatment of doughnut warts with intralesional Candida antigen immunotherapy.
    Nofal A; Fouda I; Aboelwafa H; Fawzy MM
    J Cosmet Dermatol; 2021 Jan; 20(1):295-299. PubMed ID: 32432375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunotherapeutic modalities for the treatment of recalcitrant plantar warts: a comparative study.
    Nofal A; Albalat W; Ismail A; Khattab FM
    J Dermatolog Treat; 2022 Mar; 33(2):922-927. PubMed ID: 32609022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intralesional immunotherapy with killed Mycobacterium indicus pranii vaccine for the treatment of extensive cutaneous warts.
    Singh S; Chouhan K; Gupta S
    Indian J Dermatol Venereol Leprol; 2014; 80(6):509-14. PubMed ID: 25382507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunotherapy using purified protein derivative in the treatment of warts: An open uncontrolled trial.
    Saoji V; Lade NR; Gadegone R; Bhat A
    Indian J Dermatol Venereol Leprol; 2016; 82(1):42-6. PubMed ID: 26728809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intralesional Purified Protein Derivative of Tuberculin Versus Intralesional Mycobacterium W Vaccine in Treatment of Recalcitrant Extragenital Warts: A Randomized, Single-Blinded, Comparative Study.
    Mohta A; Jain SK; Mehta RD; Arora A
    Indian J Dermatol; 2022; 67(1):26-30. PubMed ID: 35656274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intralesional immunotherapy with Mycobacterium w vaccine in patients with multiple cutaneous warts: uncontrolled open study.
    Meena JK; Malhotra AK; Mathur DK; Mathur DC
    JAMA Dermatol; 2013 Feb; 149(2):237-9. PubMed ID: 23426493
    [No Abstract]   [Full Text] [Related]  

  • 35. A comprehensive review of treatment options for recalcitrant nongenital cutaneous warts.
    Leerunyakul K; Thammarucha S; Suchonwanit P; Rutnin S
    J Dermatolog Treat; 2022 Feb; 33(1):23-40. PubMed ID: 32116076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BCG vaccine for immunotherapy in warts: is it really safe in a tuberculosis endemic area?
    Daulatabad D; Pandhi D; Singal A
    Dermatol Ther; 2016 May; 29(3):168-72. PubMed ID: 26809285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intralesional immunotherapy for difficult to treat warts with Mycobacterium w vaccine.
    Garg S; Baveja S
    J Cutan Aesthet Surg; 2014; 7(4):203-8. PubMed ID: 25722598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intralesional immunotherapy for the treatment of anogenital warts in pediatric population.
    Nofal A; Alakad R
    J Dermatolog Treat; 2022 Mar; 33(2):1042-1046. PubMed ID: 32703042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of intralesional tuberculin purified protein derivative versus cryotherapy in the treatment of warts: An assessor-blinded, randomized controlled trial.
    Wan Ahmad Kammal WSL; Jamil A; Md Nor N
    Dermatol Ther; 2021 Sep; 34(5):e15080. PubMed ID: 34351693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intralesional purified protein derivative versus zinc sulfate 2% in the treatment of pediatric warts: Clinical and dermoscopic evaluation.
    Awad A; Ismael AF; Sallam M; Abdelgaber S
    J Cosmet Dermatol; 2022 Oct; 21(10):4637-4645. PubMed ID: 35212136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.